Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor TypesASCIERTO, Paolo A; KALOS, Michael; SCHAER, David A et al.Clinical cancer research (Print). 2013, Vol 19, Num 5, pp 1009-1020, issn 1078-0432, 12 p.Article

Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies : Immunologic checkpoints for cancer treatment: from scientific rationale to clinical applicationASCIERTO, Paolo A; SIMEONE, Ester; SZNOL, Mario et al.Seminars in oncology. 2010, Vol 37, Num 5, pp 508-516, issn 0093-7754, 9 p.Article

Clinical Development of Immunostimulatory Monoclonal Antibodies and Opportunities for CombinationMELERO, Ignacio; GRIMALDI, Antonio M; PEREZ-GRACIA, Jose L et al.Clinical cancer research (Print). 2013, Vol 19, Num 5, pp 997-1008, issn 1078-0432, 12 p.Article

Intermediate dose recombinant interferon-α as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferonASCIERTO, Paolo A; DAPONTE, Antonio; PARASOLE, Rosanna et al.Cancer. 2000, Vol 89, Num 7, pp 1490-1494, issn 0008-543XArticle

Clinical genetic testing for familial melanoma in Italy: A cooperative studyBRUNO, William; GHIORZO, Paola; MANOUKIAN, Siranoush et al.Journal of the American Academy of Dermatology. 2009, Vol 61, Num 5, pp 775-782, issn 0190-9622, 8 p.Article

Clinical and dermoscopic criteria related to melanoma sentinel lymph node positivityPAGNANELLI, Gianluca; BONO, Riccardo; PIZZICHETTA, Maria A et al.Anticancer research. 2007, Vol 27, Num 4C, pp 2939-2944, issn 0250-7005, 6 p.Article

Expression of the Anti-Apoptotic Protein BAG3 in Human MelanomasFRANCO, Renato; SCOGNAMIGLIO, Giosue; SALERNO, Vincenzo et al.Journal of investigative dermatology. 2012, Vol 132, Num 1, pp 252-254, issn 0022-202X, 3 p.Article

BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: The Iitalian Melanoma Intergroup StudyCASULA, Milena; COLOMBINO, Maria; LISSIA, Amelia et al.Journal of clinical oncology. 2004, Vol 22, Num 2, pp 286-292, issn 0732-183X, 7 p.Article

Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology GroupDAPONTE, Antonio; ASCIERTO, Paolo A; GRAVINA, Adriano et al.Cancer. 2000, Vol 89, Num 12, pp 2630-2636, issn 0008-543XArticle

Adjuvant interferon alfa in malignant melanoma: An interdisciplinary and multinational expert reviewASCIERTO, Paolo A; GOGAS, Helen J; JACQUES GROB, Jean et al.Critical reviews in oncology/hematology. 2013, Vol 85, Num 2, pp 149-161, issn 1040-8428, 13 p.Article

Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic MelanomaASCIERTO, Paolo A; MINOR, David; HAMID, Omid et al.Journal of clinical oncology. 2013, Vol 31, Num 26, pp 3205-3211, issn 0732-183X, 7 p.Conference Paper

Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cellsAMANCA, Antonell; SINI, Maria Cristina; COSSU, Antonio et al.Oncology reports. 2011, Vol 25, Num 6, pp 1495-1502, issn 1021-335X, 8 p.Article

Efficacy and safety of ipilimumab 3 mg/kg in patients with pretreated, metastatic, mucosal melanomaDEL VECCHIO, Michele; DI GUARDO, Lorenza; FERRUCCI, Pier F et al.European journal of cancer (1990). 2014, Vol 50, Num 1, pp 121-127, issn 0959-8049, 7 p.Article

Novel Approaches in Melanoma Prevention and TherapyGRIMALDI, Antonio M; CASSIDY, Pamela B; LEACHMANN, Sancy et al.Cancer treatment and research. 2014, Vol 159, pp 443-455, issn 0927-3042, 13 p.Conference Paper

Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular CarcinomaGLAZER, Evan S; PICCIRILLO, Mauro; ASCIERTO, Paolo A et al.Journal of clinical oncology. 2010, Vol 28, Num 13, pp 2220-2226, issn 0732-183X, 7 p.Article

Adjuvant treatment of malignant melanoma : Where are we?ASCIERTO, Paolo A; SCALA, Stefania; OTTAIANO, Alessandro et al.Critical reviews in oncology/hematology. 2006, Vol 57, Num 1, pp 45-52, issn 1040-8428, 8 p.Article

Human melanoma metastases express functional CXCR4SCALA, Stefania; GIULIANO, Paola; CASTIGLIA, Daniele et al.Clinical cancer research. 2006, Vol 12, Num 8, pp 2427-2433, issn 1078-0432, 7 p.Article

Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assayPALMIERI, Giuseppe; ASCIERTO, Paolo A; LISSIA, Amelia et al.Journal of clinical oncology. 2001, Vol 19, Num 5, pp 1437-1443, issn 0732-183XArticle

Combined Vemurafenib and Cobimetinib in BRAF-Mutated MelanomaLARKIN, James; ASCIERTO, Paolo A; DE LA CRUZ-MERINO, Luis et al.The New England journal of medicine. 2014, Vol 371, Num 20, pp 1867-1876, issn 0028-4793, 10 p.Article

Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferonASCIERTO, Paolo A; CHIARION-SILENI, Vanna; MUGGIANO, Antonio et al.Journal of chemotherapy (Testo stampato). 2014, Vol 26, Num 4, pp 193-201, issn 1120-009X, 9 p.Article

Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination Versus Observation After Resection of Primary Tumor > 1.5 mm in Patients With Stage II Melanoma: Results of the EORTC 18961 Randomized Phase III TrialEGGERMONT, Alexander M. M; SUCIU, Stefan; BASTHOLT, Lars et al.Journal of clinical oncology. 2013, Vol 31, Num 30, pp 3831-3837, issn 0732-183X, 7 p.Article

BRAF/NRAS Mutation Frequencies Among Primary Tumors and Metastases in Patients With MelanomaCOLOMBINO, Maria; CAPONE, Mariaelena; PAGANI, Elena et al.Journal of clinical oncology. 2012, Vol 30, Num 20, pp 2522-2529, issn 0732-183X, 8 p.Article

Update on PEG-Interferon α-2b as Adjuvant Therapy in MelanomaDI TROLIO, Rossella; SIMEONE, Ester; DI LORENZO, Giuseppe et al.Anticancer research. 2012, Vol 32, Num 9, pp 3901-3909, issn 0250-7005, 9 p.Article

Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South ItalyCASULA, Milena; COLOMBINO, Maria; MOZZILLO, Nicola et al.European journal of cancer (1990). 2007, Vol 43, Num 1, pp 137-143, issn 0959-8049, 7 p.Article

Pegylated arginine deiminase treatment of patients with metastatic melanoma : Results from phase I and II studiesASCIERTO, Paolo A; SCALA, Stefania; ENSOR, C. Mark et al.Journal of clinical oncology. 2005, Vol 23, Num 30, pp 7660-7668, issn 0732-183X, 9 p.Article